Impact of Viloxazine Extended-Release Capsules (Qelbree®) on Select Cytochrome P450 Enzyme Activity and Evaluation of CYP2D6 Genetic Polymorphisms on Viloxazine Pharmacokinetics
Clinical Drug Investigation · 2024
DOI: 10.1007/s40261-024-01356-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Drug Investigation, 2024. Verfasst von Zhao Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA. zwang@supernus.com. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP2D6, Delayed-Action Preparations, Viloxazine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA. zwang@supernus.com.
- Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA.
Zitieren
APA
Wang, Z., Liranso, T., Maldonado-Cruz, Z., Kosheleff, A. R., & Nasser, A. (2024). Impact of Viloxazine Extended-Release Capsules (Qelbree®) on Select Cytochrome P450 Enzyme Activity and Evaluation of CYP2D6 Genetic Polymorphisms on Viloxazine Pharmacokinetics. Clinical Drug Investigation. https://doi.org/10.1007/s40261-024-01356-0
Vancouver
Wang Z, Liranso T, Maldonado-Cruz Z, Kosheleff AR, Nasser A. Impact of Viloxazine Extended-Release Capsules (Qelbree®) on Select Cytochrome P450 Enzyme Activity and Evaluation of CYP2D6 Genetic Polymorphisms on Viloxazine Pharmacokinetics. Clinical Drug Investigation. 2024. doi:10.1007/s40261-024-01356-0
BibTeX
@article{Wang2024,
author = {Wang, Zhao and Liranso, Tesfaye and Maldonado-Cruz, Zulane and Kosheleff, Alisa R and Nasser, Azmi},
title = {Impact of Viloxazine Extended-Release Capsules (Qelbree®) on Select Cytochrome P450 Enzyme Activity and Evaluation of CYP2D6 Genetic Polymorphisms on Viloxazine Pharmacokinetics},
journal = {Clinical Drug Investigation},
year = {2024},
doi = {10.1007/s40261-024-01356-0}
}
EUVIMED